Institute of Bioengineering and Swiss Institute of Experimental Cancer Research (ISREC)
Amanda W. Lund has not added Biography.
If you are Amanda W. Lund and would like to personalize this page please email our Author Liaison for assistance.
Encapsulation of adult human mesenchymal stem cells within collagen-agarose microenvironments.
Biotechnology and bioengineering Nov, 2005 | Pubmed ID: 16080186
Osteogenic differentiation of mesenchymal stem cells in defined protein beads.
Journal of biomedical materials research. Part B, Applied biomaterials Oct, 2008 | Pubmed ID: 18431753
Inhibition of ERK promotes collagen gel compaction and fibrillogenesis to amplify the osteogenesis of human mesenchymal stem cells in three-dimensional collagen I culture.
Stem cells and development Mar, 2009 | Pubmed ID: 18491946
The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination.
Tissue engineering. Part B, Reviews Sep, 2009 | Pubmed ID: 19505193
Role of lymphatic vessels in tumor immunity: passive conduits or active participants?
Journal of mammary gland biology and neoplasia Sep, 2010 | Pubmed ID: 20835756
Gelatin microspheres crosslinked with genipin for local delivery of growth factors.
Journal of tissue engineering and regenerative medicine Oct, 2010 | Pubmed ID: 20872738
Quantification of three-dimensional cell-mediated collagen remodeling using graph theory.
PloS one , 2010 | Pubmed ID: 20927339
Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity.
Nature reviews. Cancer Mar, 2012 | Pubmed ID: 22362216
VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics.
Cell reports Mar, 2012 | Pubmed ID: 22832193
Intravital immunofluorescence for visualizing the microcirculatory and immune microenvironments in the mouse ear dermis.
PloS one , 2013 | Pubmed ID: 23451163
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response.
Biomaterials Jan, 2014 | Pubmed ID: 24144906
Rethinking Lymphatic Vessels and Antitumor Immunity.
Trends in cancer 10, 2016 | Pubmed ID: 28741486
Lymphatic Vessels Balance Viral Dissemination and Immune Activation following Cutaneous Viral Infection.
Cell reports Sep, 2017 | Pubmed ID: 28954233
IFNγ-activated dermal lymphatic vessels inhibit cytotoxic T cells in melanoma and inflamed skin.
The Journal of experimental medicine Dec, 2018 | Pubmed ID: 30381467
Maria M. Steele1,
Madeline J. Churchill2,
Alec P. Breazeale1,
Ryan S. Lane1,
Nicholas A. Nelson1,
Amanda W. Lund1,2,3,4
1Department of Cell, Developmental, & Cancer Biology, Oregon Health and Science University,
2Department of Molecular Microbiology & Immunology, Oregon Health and Science University,
3Department of Dermatology, Oregon Health and Science University,
4Knight Cancer Institute, Oregon Health and Science University
关于 JoVE
版权所属 © 2024 MyJoVE 公司版权所有,本公司不涉及任何医疗业务和医疗服务。